Table 2.
Hypertension Treatment Status, Overall and By Pregnancy Status
| Variables | Overall (N = 5972) |
Not Pregnant (N = 5860) |
Pregnant (N = 112) |
P value |
|---|---|---|---|---|
| Walk-in Treatment [n (%)] | 2503 (41.9%) | 2467 (42.1%) | 36 (32.1%) | 0.03 |
| Drug Class [n (%)] | < 0.001 | |||
| Calcium Channel Blockers | 1871 (74.8%) | 1853 (75.1%) | 18 (50.0%) | |
| ACE/ARB/Diuretics | 339 (13.5%) | 336 (13.6%) | 3 (8.3%) | |
| Beta Blockers | 13 (0.5%) | 13 (0.5%) | 0 (0%) | |
| Aspirin | 20 (0.8%) | 20 (0.8%) | 0 (0%) | |
| Methyldopa/Other | 260 (10.4%) | 245 (4.2%) | 15 (41.7%) | |
| Walk-out Treatment [n (%)]º | 5319 (89.1%) | 5248 (89.6%) | 71 (63.4%) | < 0.001 |
| Drug Class [n (%)] | ||||
| Calcium Channel Blockers | 4998 (94.0%) | 4953 (94.4%) | 45 (63.4%) | |
| ACE/ARB/Diuretics | 1295 (24.3%) | 1284 (24.5%) | 11 (15.5%) | |
| Beta Blockers | 5 (0.09%) | 5 (0.1%) | 0 (0%) | |
| Aspirin | 6 (0.1%) | 6 (0.1%) | 0 (0%) | |
| Methyldopa/Other | 114 (2.1%) | 94 (1.8%) | 20 (28.2%) | |
| New Treatment | 3253 (54.5%) | 3208 (54.7%) | 45 (40.2%)† | |
| No Treatment | 216 (3.6%) | 185 (3.2%) | 31 (27.7%) | |
| Stopped Treatment | 315 (5.3%) | 305 (5.2%) | 10 (8.9%) | |
| Continued/Altered Treatment | 2503 (36.6%) | 2162 (36.9%) | 26 (23.2%)† |
oout of 8 pregnant women, 3 were prescribed ARB and 5 were prescribed diuretics. †4 previously unmedicated pregnant patients were prescribed contraindicated medications; 4 previously medicated patients were prescribed contraindicated medications; walk-in treatment and walk-out treatment rates are the rates at the start and at the end of patients’ baseline visits respectively